Key result
Common chromosome 4q25 variants linked to increased AF risk in rare cardiac mutation carriers.
Why the study?
Penetrance of familial atrial fibrillation caused by ion channel and signaling molecule mutations is highly variable, and the role of common 4q25 polymorphisms as modifiers was unclear.
Do common chromosome 4q25 polymorphisms modify the penetrance and clinical expression of atrial fibrillation in carriers of rare familial ion channel mutations?
Observational (n=50)
Do common chromosome 4q25 polymorphisms modify the penetrance and clinical expression of atrial fibrillation in carriers of rare familial ion channel mutations?
Common genetic variants at chromosome 4q25 modify the penetrance of rare familial ion channel mutations, explaining the variable clinical expression of atrial fibrillation in affected families.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“One reasonable view is that "genetic background," captured by single-nucleotide variants (SNVs) across multiple susceptibility pathways, can itself predispose to AF or modulate penetrance of rarer high-effect size variants captured by family studies”
4q25 alleles were associated with AF penetrance in rare-mutation carriers; hypothesis-generating and should not yet change genetic counseling or testing.
Objectives This study tested the hypothesis that two common polymorphisms in the chromosome 4q25 region that have been associated with atrial fibrillation (AF) contribute to the variable penetrance of familial AF. Background Although mutations in ion channels, gap junction proteins, and signaling molecules have been described for Mendelian forms of AF, penetrance is highly variable. Recent studies have consistently identified 2 common single nucleotide polymorphisms (SNPs) in the chromosome 4q25 region as independent AF susceptibility alleles. Methods We studied 11 families in which AF was present in ≥2 individuals who also shared a candidate gene mutation. These mutations were identified in all subjects with familial lone AF (n=33) as well as apparently unaffected family members (age >50 yrs with no AF; n=17). Results Mutations were identified in SCN5A (n=6); NPPA (n=2); KCNQ1 (n=1); KCNA5 (n=1) and NKX2.5 (n=1). In genetic association analyses, un-stratified and stratified according to age of onset of AF and unaffected age > 50 yrs, there was a highly statistically significant association between the presence of both common (rs2200733, rs10033464) as well as rare variants and AF (un-stratified P=1×10−8; stratified [age of onset <50 yrs and unaffected age >50 yrs], P=7.6×10−5) (un-stratified P<0.0001; stratified [age of onset <50 yrs and unaffected age >50 yrs], P<0.0001). Genetic association analyses showed that the presence of common 4q25 risk alleles predicted whether carriers of rare mutations developed AF (P = 2.2×10−4). Conclusions Common AF-associated 4q25 polymorphisms modify the clinical expression of latent cardiac ion channel and signaling molecule gene mutations associated with familial AF. These findings support the idea that the genetic architecture of AF is complex and includes both rare and common genetic variants.
No takes yet. Share an insight, caveat, or question.
Ritchie et al. (2012) conducted an observational in Familial Atrial Fibrillation (n=50). Common chromosome 4q25 polymorphisms (rs2200733, rs10033464) vs. Absence of risk alleles was evaluated on Development of atrial fibrillation in carriers of rare mutations (p=2.2×10−4). The presence of common chromosome 4q25 risk alleles significantly predicted the development of atrial fibrillation in carriers of rare cardiac gene mutations (P=2.2x10-4).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: